InvestorsHub Logo
Followers 4
Posts 121
Boards Moderated 0
Alias Born 08/10/2005

Re: None

Sunday, 06/28/2015 12:23:46 PM

Sunday, June 28, 2015 12:23:46 PM

Post# of 15799
BioTrades DR. MICHAEL MELTZER on Opko Health

DD ON OPK BY DR. MICHAEL MELTZER

Excerpt:

My conclusion:
After tough early years involving many financing dilutions we are now entering the peak growth years for OPK. I really love the risk/reward here. Risks being both companies heavily shorted creating a rocky near term till merger. Merger still needs approval of BRLI shareholders who will be getting a significant premium at 2 3/4 OPK shares/BRLI share. Rayaldee and the Peptide Platform must still be approved and proved out respectively. On the other hand if all goes right OPK should become one of the largest biotechs as all their products will have the high margins associated with products with no competition. Profits in the area of $10B is not impossible nor is a triple digit stock price.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OPK News